ARCH Venture Partners portfolio
96 tracked investments, 13 on the map, $3.8B raised across the mapped portfolio.
- Xaira Therapeutics
- Generate BiomedicinesSeries C
- eGenesis
- Aspen NeuroscienceSeries C
- Seaport Therapeutics
- Synchron
- Mirador TherapeuticsSeries B
- Encoded TherapeuticsSeries D
- Amphora DiscoverySeries E
- bit.bio
- Paradigm
- KSQ TherapeuticsSeries C
- Quantum Circuits
Also in the portfolio
- Alnylam Pharmaceuticals
- Kardigan
- Vizgen
- Elephas
- Altos Labs
- Lightcast Discovery
- Resilience
- Homeward
- Rapport Therapeutics
- Pretzel Therapeutics
- Treeline Biosciences
- Tenvie Therapeutics
- LifeMine Therapeutics
- Rippl Care
- Arbor Biotechnologies
- Be Biopharma
- Dewpoint Therapeutics
- Magnet Biomedicine
- Boundless Bio
- ArsenalBio
- Illumina
- AIRNA
- Chroma Medicine
- Accompany Health
- HI-Bio
- Volastra Therapeutics
- Aira
- City Therapeutics
- Cytrellis Biosystems
- Brii Biosciences
- Beam Therapeutics
- Denali Therapeutics
- Agios Pharmaceuticals
- HiberCell
- AgBiome
- Matter Neuroscience
- Genetix Biotherapeutics Inc.
- Paratus Sciences
- Protillion Biosciences
- Semma Therapeutics
- Fate Therapeutics
- Walden Biosciences
- Proof Diagnostics
- Karuna Therapeutics
- AmberWave
- Agrivida
- ONI
- Happy Health
- Cooledge Lighting
- LunaDNA
- Homology Medicines
- Omniome
- Bellerophon Therapeutics
- Adesto Technologies
- Nanophase Technologies
- PRIME Coalition
- Chiasma
- Sapphire Energy
- Cambrios Technologies
- Medvantx